Oncotarget

Research Papers:

uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model

Anders Christensen _, Karina Juhl, Morten Persson, Birgitte Wittenborg Charabi, Jann Mortensen, Katalin Kiss, Giedrius Lelkaitis, Niclas Rubek, Christian von Buchwald and Andreas Kjær

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:15407-15419. https://doi.org/10.18632/oncotarget.14282

Metrics: PDF 3081 views  |   HTML 3790 views  |   ?  


Abstract

Anders Christensen1,2, Karina Juhl2, Morten Persson2, Birgitte Wittenborg Charabi1, Jann Mortensen2, Katalin Kiss3, Giedrius Lelkaitis3, Niclas Rubek2, Christian von Buchwald1, Andreas Kjær2

1Department of Otolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Denmark

2Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark

3Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Denmark

Correspondence to:

Andreas Kjær, email: [email protected]

Keywords: uPAR, image-guided surgery, tumor margin assessment, head and neck cancer, robotic surgery, PET

Received: August 26, 2016     Accepted: November 30, 2016     Published: December 27, 2016

ABSTRACT

Purpose: Urokinase-like Plasminogen Activator Receptor (uPAR) is overexpressed in a variety of carcinoma types, and therefore represents an attractive imaging target. The aim of this study was to assess the feasibility of two uPAR-targeted probes for PET and fluorescence tumor imaging in a human xenograft tongue cancer model.

Experimental design and results: Tumor growth of tongue cancer was monitored by bioluminescence imaging (BLI) and MRI. Either ICG-Glu-Glu-AE105 (fluorescent agent) or 64Cu-DOTA-AE105 (PET agent) was injected systemically, and fluorescence imaging or PET/CT imaging was performed. Tissue was collected for micro-fluorescence imaging and histology. A clear fluorescent signal was detected in the primary tumor with a mean in vivo tumor-to-background ratio of 2.5. Real-time fluorescence-guided tumor resection was possible, and sub-millimeter tumor deposits could be localized. Histological analysis showed co-localization of the fluorescent signal, uPAR expression and tumor deposits. In addition, the feasibility of uPAR-guided robotic cancer surgery was demonstrated. Also, uPAR-PET imaging showed a clear and localized signal in the tongue tumors.

Conclusions: This study demonstrated the feasibility of combining two uPAR-targeted probes in a preclinical head and neck cancer model. The PET modality provided preoperative non-invasive tumor imaging and the optical modality allowed for real-time fluorescence-guided tumor detection and resection. Clinical translation of this platform seems promising.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14282